TrialHuman vaccines & immunotherapeutics2021

Safety, reactogenicity, and immunogenicity of a 12-valent pneumococcal non-typeable

Michael Horn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.